Filed Pursuant to Rule 433
Registration No. 333-261901-20
**PRICED** $1.69+B SDART 2024-5 SUBPRIME AUTO ABS
Joint Lead Bookrunners: Wells Fargo Securities (str), Citi, Mizuho, and Santander US Capital Markets
DE&I coordinator: Wells Fargo
DE&I co-managers: Cabrera Capital Markets, LLC and AmeriVet Securities, Inc.
-CAPITAL STRUCTURE-
| | | | | | | | | | | | | | | | | | | | | | |
Class | | Size ($MM) | | WAL* | | Moody’s/Fitch | | P.WIN | | E.FNL | | L.FNL | | BNCH | | SPRD | | YLD% | | CPN% | | $PX |
=========================================================================================================== |
A-1 | | 199.930 | | 0.10 | | P-1/F1+ | | 01-03 | | 01/25 | | 10/25 | | ICUR | | <N/O> | | | | |
A-2 | | 563.580 | | 0.61 | | Aaa/AAA | | 03-14 | | 12/25 | | 09/27 | | ICUR | | 57 | | 4.937 | | 4.880 | | 99.99606 |
A-3 | | 325.950 | | 1.54 | | Aaa/AAA | | 14-24 | | 10/26 | | 11/28 | | ICUR | | 63 | | 4.667 | | 4.620 | | 99.99683 |
B | | 206.620 | | 2.29 | | Aaa/AA | | 24-32 | | 06/27 | | 08/29 | | ICUR | | 77 | | 4.680 | | 4.630 | | 99.98933 |
C | | 187.840 | | 2.97 | | Aa2/A | | 32-41 | | 03/28 | | 01/31 | | ICUR | | 98 | | 4.831 | | 4.780 | | 99.99167 |
D | | 216.010 | | 3.70 | | Baa2/BBB | | 41-46 | | 08/28 | | 02/32 | | ICUR | | 135 | | 5.198 | | 5.140 | | 99.99152 |
=========================================================================================================== |
*1.50% ABS to 10.00% Clean-Up Call
-TRANSACTION SUMMARY-
Size: $1.69+b (NO GROW)
Format: SEC Registered
ERISA: Yes
Min Denoms: 1k x 1k
Expected Ratings: Moody’s / Fitch
Ticker: SDART 2024-5
First Interest Payment: 11/15/2024
Exp. Settle: 10/29/2024
B&D: Wells Fargo
-MARKETING MATERIALS-
Preliminary Prospectus: attached
FWP: attached
Intex CDI: attached
Intexnet Deal Name: wssdart_2405 Password: V369
Dealroadshow: https://dealroadshow.com Code: SDART2024-5
Dealroadshow Direct Link: https://dealroadshow.com/e/SDART2024-5
If this communication relates to an offering of US registered securities (i) a registration statement has been filed with the SEC, (ii) before investing you should read the filed documents, and (iii) you may obtain these documents from your sales representative, by calling 1-800-645-3751 or visiting www.sec.gov. If this communication relates to a securities offering exempt from US registration, you should contact your sales representative for the complete disclosure package. For information regarding Wells Fargo, see https://www.wellsfargo.com/com/disclaimer/ged5. In Asia, see: https://www.wellsfargo.com/com/disclaimer/ap4. This communication will be retained and may be monitored.